These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2666615)

  • 61. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Local angiotensin II generation in the rat heart: role of renin uptake.
    Müller DN; Fischli W; Clozel JP; Hilgers KF; Bohlender J; Ménard J; Busjahn A; Ganten D; Luft FC
    Circ Res; 1998 Jan 9-23; 82(1):13-20. PubMed ID: 9440700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of endogenous angiotensin II in the control of vasopressin secretion during hypovolemia and hypotension in conscious rabbits.
    Matsukawa S; Keil LC; Reid IA
    Endocrinology; 1991 Jan; 128(1):204-10. PubMed ID: 1986918
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
    Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H679-87. PubMed ID: 9124424
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure.
    Clozel JP; Véniant MM; Qiu C; Sprecher U; Wolfgang R; Fischli W
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):674-82. PubMed ID: 10547083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Angiotensin II formation by an alternative pathway during exercise in humans.
    Miura S; Ideishi M; Sakai T; Motoyama M; Kinoshita A; Sasaguri M; Tanaka H; Shindo M; Arakawa K
    J Hypertens; 1994 Oct; 12(10):1177-81. PubMed ID: 7836734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects.
    Niarchos AP; Pickering TG; Case DB; Sullivan P; Laragh JH
    Circ Res; 1979 Dec; 45(6):829-37. PubMed ID: 498446
    [No Abstract]   [Full Text] [Related]  

  • 71. Neurohumoral vasoconstrictor systems in heart failure.
    Riegger AJ
    Eur Heart J; 1985 Jun; 6(6):479-89. PubMed ID: 2864248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
    Richer C; Doussau MP; Giudicelli JF
    Hypertension; 1983; 5(3):312-20. PubMed ID: 6188693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS; Gavras H; Hood WB
    J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
    [TBL] [Abstract][Full Text] [Related]  

  • 76. H-77: a potent new renin inhibitor. In vitro and in vivo studies.
    Szelke M; Leckie BJ; Tree M; Brown A; Grant J; Hallett A; Hughes M; Jones DM; Lever AF
    Hypertension; 1982; 4(3 Pt 2):59-69. PubMed ID: 7040240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interaction between angiotensin II and the baroreceptor reflex in the control of adrenocorticotropic hormone secretion and heart rate in conscious dogs.
    Brooks VL; Reid IA
    Circ Res; 1986 Jun; 58(6):816-28. PubMed ID: 3013462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
    Manson NH; Hess ML
    Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
    Davidson D; Stalcup SA
    J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.